Literature DB >> 26404610

Draft Genome Sequence of Methicillin-Sensitive Staphylococcus aureus ATCC 29213.

Isha Soni1, Harinath Chakrapani2, Sidharth Chopra3.   

Abstract

Staphylococcus aureus subsp. aureus ATCC 29213 is one of the most commonly used strains in drug discovery research and for quality control. We report the completed draft genome sequence for the strain.
Copyright © 2015 Soni et al.

Entities:  

Year:  2015        PMID: 26404610      PMCID: PMC4582586          DOI: 10.1128/genomeA.01095-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Staphylococcus aureus is an opportunistic human nosocomial and community-associated pathogen that causes a wide spectrum of infections ranging from skin and skin structure infections to bacteremia and necrotizing pneumonia (1). It has developed into a successful pathogen, owing to its numerous virulence factors and its resistance to a multitude of antibiotics, which narrows the options available for its treatment. Recently, a number of genomic efforts have been directed toward understanding the genetic basis of antimicrobial resistance and virulence by comparing the genomes of drug-resistant strains to those of drug-susceptible strains (2, 3). This has been hampered, however, by the unavailability of genomes of a number of drug-susceptible strains, especially those that are methicillin-susceptible, and thus our quest to determine the genome sequence of Staphylococcus aureus ATCC 29213. Staphylococcus aureus subsp. aureus ATCC 29213 is a clinical isolate with the designation Wichita that is utilized as a standard quality-control strain in laboratory testing. It is sensitive to a large variety of antimicrobials, including methicillin. Staphylococcus aureus subsp. aureus ATCC 29213 was purchased from American Type Culture Collection (ATCC) and was grown overnight at 37°C in Mueller-Hinton broth (Becton, Dickinson) and genomic DNA was extracted using QiAmp DNA minikit (Qiagen) according to the manufacturer’s instructions. The whole genome was sequenced on the Ion Torrent PGM system (Life Technologies) following the manufacturer’s protocols for 200-bp genomic DNA (gDNA) fragment library preparation (Ion Xpress Plus gDNA and Amplicon Library Preparation), template preparation (Ion OneTouch system), and sequencing (Ion PGM 200 sequencing kit). A total of 363 Mb of data were obtained with an accumulated length of 320,957,160 bp (115× fold coverage). A total of 147 contigs were assembled using Assembler SPAdes version 4.4.0.1 to give a genome length of 2,773,559 bp with an average GC content of 34%. The annotation was carried out using RAST version 2.0 (http://rast.nmpdr.org; [4]). A total of 2,907 open reading frames were predicted, out of which 780 (26.8%) had an assigned function and 32 (1.1%) were conserved hypothetical, while the remaining 812 (27.9%) were classified as either of unknown function and/or hypothetical proteins with 53 tRNAs as well as 9 rRNAs. The detailed genomic data analysis from this de novo genome assembly is under way to obtain a finer resolution. Overall, the availability of the genome sequence of methicillin-sensitive S. aureus ATCC 29213 facilitates additional comparative genomic and bioinformatics analysis of drug-resistance mechanisms in S. aureus.

Nucleotide sequence accession number.

This whole-genome project has been deposited in DDBJ/EMBL/Genbank under the accession number LHUS00000000.
  4 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands.

Authors:  Tadashi Baba; Taeok Bae; Olaf Schneewind; Fumihiko Takeuchi; Keiichi Hiramatsu
Journal:  J Bacteriol       Date:  2007-10-19       Impact factor: 3.490

3.  Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210.

Authors:  David R Cameron; Jhih-Hang Jiang; Iain J Abbott; Denis W Spelman; Anton Y Peleg
Journal:  Genome Announc       Date:  2015-06-11

4.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

  4 in total
  12 in total

1.  Determinants of Antibacterial Spectrum and Resistance Potential of the Elongation Factor G Inhibitor Argyrin B in Key Gram-Negative Pathogens.

Authors:  Adriana K Jones; Angela L Woods; Kenneth T Takeoka; Xiaoyu Shen; Jun-Rong Wei; Ruth E Caughlan; Charles R Dean
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

2.  The Quinazolinone Allosteric Inhibitor of PBP 2a Synergizes with Piperacillin and Tazobactam against Methicillin-Resistant Staphylococcus aureus.

Authors:  Jeshina Janardhanan; Renee Bouley; Siseth Martínez-Caballero; Zhihong Peng; Mayte Batuecas-Mordillo; Jayda E Meisel; Derong Ding; Valerie A Schroeder; William R Wolter; Kiran V Mahasenan; Juan A Hermoso; Shahriar Mobashery; Mayland Chang
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

3.  Decompression effects on bone healing in rat mandible osteomyelitis.

Authors:  Buyanbileg Sodnom-Ish; Mi Young Eo; Ji Hye Oh; Mi Hyun Seo; Hoon Joo Yang; Jong Ho Lee; Soung Min Kim
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

4.  The ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential.

Authors:  Michael M Maiden; Mitchell P Zachos; Christopher M Waters
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.758

5.  Comparative virulence studies and transcriptome analysis of Staphylococcus aureus strains isolated from animals.

Authors:  Zahid Iqbal; Mohamed N Seleem; Hafiz Iftikhar Hussain; Lingli Huang; Haihong Hao; Zonghui Yuan
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

6.  Efficient and Scalable Precision Genome Editing in Staphylococcus aureus through Conditional Recombineering and CRISPR/Cas9-Mediated Counterselection.

Authors:  Kelsi Penewit; Elizabeth A Holmes; Kathyrn McLean; Mingxin Ren; Adam Waalkes; Stephen J Salipante
Journal:  MBio       Date:  2018-02-20       Impact factor: 7.867

7.  Hydrogels Embedded With Melittin and Tobramycin Are Effective Against Pseudomonas aeruginosa Biofilms in an Animal Wound Model.

Authors:  Michael M Maiden; Mitchell P Zachos; Christopher M Waters
Journal:  Front Microbiol       Date:  2019-06-20       Impact factor: 6.064

8.  Microwaves increase the effectiveness of systemic antibiotic treatment in acute bone infection: experimental study in a rat model.

Authors:  Xiao-Yang Qi; Xu-Sheng Qiu; Jiang-Yun Jiang; Yi-Xin Chen; Li-Ming Tang; Hong-Fei Shi
Journal:  J Orthop Surg Res       Date:  2019-09-06       Impact factor: 2.359

9.  Untargeted Metabolomics Reveals Species-Specific Metabolite Production and Shared Nutrient Consumption by Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Laura J Dunphy; Kassandra L Grimes; Nishikant Wase; Glynis L Kolling; Jason A Papin
Journal:  mSystems       Date:  2021-06-22       Impact factor: 6.496

10.  Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development.

Authors:  Samuel Jacques; Almer M van der Sloot; Caroline C Huard; Jasmin Coulombe-Huntington; Sarah Tsao; Sylvain Tollis; Thierry Bertomeu; Elizabeth J Culp; Daniel Pallant; Michael A Cook; Eric Bonneil; Pierre Thibault; Gerard D Wright; Mike Tyers
Journal:  Genetics       Date:  2020-02-24       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.